Dynavax Technologies - 48 Year Dividend History | DVAX

Historical dividend payout and yield for Dynavax Technologies (DVAX) since 1971. The current TTM dividend payout for Dynavax Technologies (DVAX) as of April 23, 2019 is $0.00. The current dividend yield for Dynavax Technologies as of April 23, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.407B $0.008B
Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.629B 12.24
Gilead Sciences (GILD) United States $78.878B 10.04
Bio-Techne Corp (TECH) United States $7.219B 48.64